(Q48350996)

English

Treatment patterns, visual acuity and quality-of-life outcomes of the WAVE study - a noninterventional study of ranibizumab treatment for neovascular age-related macular degeneration in Germany

scientific article published on 22 November 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23171290

Treatment patterns, visual acuity and quality-of-life outcomes of the WAVE study - a noninterventional study of ranibizumab treatment for neovascular age-related macular degeneration in Germany (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23171290

0 references

quality of life

1 reference

based on heuristic

inferred from title

macular degeneration

1 reference

based on heuristic

inferred from title

Robert P Finger

1

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23171290

5

object named as

Frank G Holz

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23171290

author name string

Peter Wiedemann

2

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23171290

Francisca Blumhagen

3

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23171290

Karin Pohl

4

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23171290

publication date

22 November 2012

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23171290

Acta Ophthalmologica

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23171290

91

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23171290

6

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23171290

540-546

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23171290

Effectiveness of intravitreal ranibizumab for the treatment of neovascular age-related macular degeneration in a Canadian retina practice: a retrospective review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2012.02493.X

21 January 2018

Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2012.02493.X

21 January 2018

A Phase IIIb study to evaluate the safety of ranibizumab in subjects with neovascular age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2012.02493.X

21 January 2018

Risks of Mortality, Myocardial Infarction, Bleeding, and Stroke Associated With Therapies for Age-Related Macular Degeneration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2012.02493.X

21 January 2018

Interobserver variability for retreatment indications after Ranibizumab loading doses in neovascular age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2012.02493.X

21 January 2018

An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2012.02493.X

21 January 2018

Effectiveness of ranibizumab for neovascular age-related macular degeneration using clinician-determined retreatment strategy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2012.02493.X

21 January 2018

Delay to treatment and visual outcomes in patients treated with anti-vascular endothelial growth factor for age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2012.02493.X

21 January 2018

The psychometric validity of the NEI VFQ-25 for use in a low-vision population

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2012.02493.X

21 January 2018

Monitoring of AMD patients on anti-vascular endothelial growth factor (VEGF) treatment. Practical notes on functional and anatomical examination parameters from drug approval studies, specialist information and case series

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2012.02493.X

21 January 2018

Incidence of rhegmatogenous retinal detachments after intravitreal antivascular endothelial factor injections.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2012.02493.X

21 January 2018

Reliability and validity of the National Eye Institute Visual Function Questionnaire-25 in patients with age-related macular degeneration.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2012.02493.X

21 January 2018

Ranibizumab for neovascular age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2012.02493.X

21 January 2018

Time between symptom onset and assessment in age-related macular degeneration with subfoveal choroidal neovascularization

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2012.02493.X

21 January 2018

Identifiers

10.1111/J.1755-3768.2012.02493.X

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23171290

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23171290

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48350996&oldid=2195725660"